We found reduced LYNX1 expression that via tPA-dependent mechanism could affect process growth in FXS NPCs and may in combination with patient-specific transcriptional regulation of genes related to epilepsy contribute to the FXS epilepsy phenotype. This evidence concerns the gene LYNX1 and fragile X syndrome.